NO20016004L - Sammensetning som innbefatter alkalisk sfingomyelinase for anvendelse som et dietetisk preparat, n¶ringsmiddeltilskudd ellerfarmasöytisk produkt - Google Patents

Sammensetning som innbefatter alkalisk sfingomyelinase for anvendelse som et dietetisk preparat, n¶ringsmiddeltilskudd ellerfarmasöytisk produkt

Info

Publication number
NO20016004L
NO20016004L NO20016004A NO20016004A NO20016004L NO 20016004 L NO20016004 L NO 20016004L NO 20016004 A NO20016004 A NO 20016004A NO 20016004 A NO20016004 A NO 20016004A NO 20016004 L NO20016004 L NO 20016004L
Authority
NO
Norway
Prior art keywords
dietetic
composition
pharmaceutical product
nutritional supplement
alkaline sphingomyelinase
Prior art date
Application number
NO20016004A
Other languages
English (en)
Other versions
NO327862B1 (no
NO20016004D0 (no
Inventor
Claudio De Simone
Original Assignee
Vsl Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11406823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20016004(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vsl Pharma Ltd filed Critical Vsl Pharma Ltd
Publication of NO20016004D0 publication Critical patent/NO20016004D0/no
Publication of NO20016004L publication Critical patent/NO20016004L/no
Publication of NO327862B1 publication Critical patent/NO327862B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/04—Phosphoric diester hydrolases (3.1.4)
    • C12Y301/04012—Sphingomyelin phosphodiesterase (3.1.4.12)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/195—Proteins from microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
NO20016004A 1999-06-09 2001-12-07 Sammensetning som innbefatter alkalisk sfingomyelinase av bakterielt opphav for anvendelse som et dietetisk preparat, ernaeringstilskudd eller farmasoytisk produkt, samt anvendelse av denne alkaliske sfingomyelinase for fremstilling av et dietetisk preparat, et ernaeringstilskudd eller et farmasoytisk produkt. NO327862B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000376A IT1311495B1 (it) 1999-06-09 1999-06-09 Composizione comprendente sfingomielinasi alcalina, utilizzabile qualeprodotto dietetico, integratore alimentare o medicamento.
PCT/IT2000/000230 WO2000074712A2 (en) 1999-06-09 2000-06-07 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product

Publications (3)

Publication Number Publication Date
NO20016004D0 NO20016004D0 (no) 2001-12-07
NO20016004L true NO20016004L (no) 2002-02-06
NO327862B1 NO327862B1 (no) 2009-10-05

Family

ID=11406823

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016004A NO327862B1 (no) 1999-06-09 2001-12-07 Sammensetning som innbefatter alkalisk sfingomyelinase av bakterielt opphav for anvendelse som et dietetisk preparat, ernaeringstilskudd eller farmasoytisk produkt, samt anvendelse av denne alkaliske sfingomyelinase for fremstilling av et dietetisk preparat, et ernaeringstilskudd eller et farmasoytisk produkt.

Country Status (34)

Country Link
US (2) US20020031507A1 (no)
EP (1) EP1181047B9 (no)
JP (2) JP4897167B2 (no)
KR (1) KR100812806B1 (no)
CN (3) CN101695374B (no)
AR (1) AR024564A1 (no)
AT (1) ATE237350T1 (no)
AU (1) AU778946B2 (no)
BR (1) BR0011447A (no)
CA (1) CA2376048C (no)
CZ (1) CZ296369B6 (no)
DE (1) DE60002194T3 (no)
DK (1) DK1181047T4 (no)
DZ (1) DZ3160A1 (no)
EA (1) EA005166B1 (no)
EE (1) EE05491B1 (no)
EG (1) EG24675A (no)
ES (1) ES2195902T5 (no)
HK (1) HK1046246A1 (no)
HU (1) HU228941B1 (no)
IL (2) IL146888A0 (no)
IS (1) IS2742B (no)
IT (1) IT1311495B1 (no)
MA (1) MA26792A1 (no)
MX (1) MXPA01012641A (no)
NO (1) NO327862B1 (no)
PL (1) PL214675B1 (no)
PT (1) PT1181047E (no)
SI (1) SI1181047T2 (no)
SK (1) SK285901B6 (no)
TR (1) TR200103566T2 (no)
UA (1) UA80799C2 (no)
WO (1) WO2000074712A2 (no)
ZA (1) ZA200200039B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1311495B1 (it) * 1999-06-09 2002-03-13 Mendes S U R L Composizione comprendente sfingomielinasi alcalina, utilizzabile qualeprodotto dietetico, integratore alimentare o medicamento.
IE20011100A1 (en) * 2001-12-21 2003-07-09 Vsl Pharma Ltd Analytical Method for Detecting Alkaline Sphingomyelinase and Kit for Use in Such Method
US9655932B2 (en) 2002-03-13 2017-05-23 Kibow Biotech, Inc. Composition and method for preventing or treating gout or hyperuricemia
US11103542B2 (en) 2002-03-13 2021-08-31 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
US20050074442A1 (en) * 2002-03-13 2005-04-07 Natarajan Ranganathan Compositions and methods for augmenting kidney function
US9980988B2 (en) 2002-03-13 2018-05-29 Kibow Biotech, Inc. Compositions and methods for augmenting kidney function
KR100568036B1 (ko) * 2004-08-12 2006-04-07 하남주 장기능 활성화 및 면역기능 강화작용을 하는비피도박테리움 균주 및 이를 함유하는 생균제제
KR100610379B1 (ko) * 2004-08-26 2006-08-10 하남주 면역 증강 활성을 가지는 신규 유산균
TW200837194A (en) * 2007-03-06 2008-09-16 Microbio Company Ltd Taiwan Fermented panax notoginseng solution with anti-cancer effects and manufacture method thereof
KR100868777B1 (ko) * 2007-03-15 2008-11-17 재단법인서울대학교산학협력재단 Ｒｓ３ 유형의 저항 전분에 대해 분해능이 있는비피도박테리움 아도레스센티스를 유효성분으로 함유하는것을 특징으로 하는 식품 조성물
EP2270133B1 (en) 2008-04-22 2015-06-24 Corporación Alimentaria Peñasanta (Capsa) Method for obtaining a novel strain of bifidobacterium bifidum with activity against infection by helicobacter pylori
ES2395529B1 (es) 2011-06-08 2014-04-11 Pri, S.A. Combinación sinérgica para el tratamiento de la diabetes mellitus tipo 2.
KR101364695B1 (ko) * 2011-06-29 2014-02-19 가천대학교 산학협력단 헬리코박터 파이로리의 생육을 저해하는 타락 유래 젖산균
US20150284675A1 (en) * 2012-10-25 2015-10-08 Compagnie Gervais Danone Streptococcus thermophilus strains for treating helicobacter pylori infection
KR101479818B1 (ko) * 2012-12-17 2015-01-26 주식회사 알엔에이 유산균 파쇄물의 제조방법
TW201630596A (zh) * 2015-01-06 2016-09-01 Meiji Co Ltd 鞘脂質吸收促進劑
JP7088829B2 (ja) 2016-04-13 2022-06-21 株式会社明治 新生児向けの脳機能改善用組成物
WO2018125735A1 (en) 2016-12-29 2018-07-05 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55120787A (en) † 1979-03-09 1980-09-17 Teruhiko Beppu Preparation of sphingomyelinase
JPS60221084A (ja) * 1984-04-18 1985-11-05 Chiyoda Chem Eng & Constr Co Ltd スフインゴミエリナ−ゼの製造法
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
JP2676484B2 (ja) * 1994-03-28 1997-11-17 熊本県 ヨーグルト様乳酸発酵食品の製造方法
JP3122333B2 (ja) * 1995-02-28 2001-01-09 株式会社薬理学中央研究所 赤血球を原料とするスフィンゴミエリンおよびセラミドの新規製造方法とセラミド配合治療剤又は化粧品
JP4021951B2 (ja) * 1996-03-01 2007-12-12 わかもと製薬株式会社 乳酸菌を有効成分とする抗胃炎剤、抗潰瘍剤および醗酵食品
JP3530674B2 (ja) * 1996-03-04 2004-05-24 明治乳業株式会社 変異原性物質吸収阻害性食品
IT1288119B1 (it) * 1996-06-28 1998-09-10 Renata Maria Anna Ve Cavaliere Composizioni dietetiche da utilizzare nell'alimentazione per via enterica
IT1296148B1 (it) * 1996-11-22 1999-06-09 Renata Maria Anna Ve Cavaliere Uso di batteri lattici per accrescere il livello delle ceramidi della pelle e delle mucose, e composizioni dermatologiche e cosmetiche atte
JP3400282B2 (ja) * 1997-02-21 2003-04-28 株式会社ヤクルト本社 脂質代謝改善剤およびそれを含有する食品
IT1298918B1 (it) * 1998-02-20 2000-02-07 Mendes Srl Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
IT1311495B1 (it) * 1999-06-09 2002-03-13 Mendes S U R L Composizione comprendente sfingomielinasi alcalina, utilizzabile qualeprodotto dietetico, integratore alimentare o medicamento.

Also Published As

Publication number Publication date
HU228941B1 (en) 2013-07-29
PL214675B1 (pl) 2013-09-30
NO327862B1 (no) 2009-10-05
CA2376048A1 (en) 2000-12-14
KR20020016826A (ko) 2002-03-06
AU778946B2 (en) 2004-12-23
BR0011447A (pt) 2002-03-19
US20020031507A1 (en) 2002-03-14
NO20016004D0 (no) 2001-12-07
JP4897167B2 (ja) 2012-03-14
AR024564A1 (es) 2002-10-16
EE05491B1 (et) 2011-12-15
EP1181047A2 (en) 2002-02-27
SK285901B6 (sk) 2007-10-04
ES2195902T9 (es) 2011-03-01
ZA200200039B (en) 2002-12-24
HUP0201631A2 (hu) 2005-12-28
MXPA01012641A (es) 2004-03-19
CN101695374B (zh) 2015-08-19
TR200103566T2 (tr) 2002-05-21
EA005166B1 (ru) 2004-12-30
KR100812806B1 (ko) 2008-03-12
JP2012040015A (ja) 2012-03-01
PT1181047E (pt) 2003-09-30
IT1311495B1 (it) 2002-03-13
SK17162001A3 (sk) 2002-03-05
CZ296369B6 (cs) 2006-02-15
IS6178A (is) 2001-11-27
HK1046246A1 (zh) 2003-01-03
ITRM990376A1 (it) 2000-12-09
UA80799C2 (uk) 2007-11-12
EE200100661A (et) 2003-04-15
US20050084486A1 (en) 2005-04-21
HUP0201631A3 (en) 2006-02-28
CN1354672A (zh) 2002-06-19
CA2376048C (en) 2014-12-09
ES2195902T3 (es) 2003-12-16
PL364729A1 (en) 2004-12-13
EA200200019A1 (ru) 2002-06-27
IL146888A0 (en) 2002-08-14
DK1181047T4 (da) 2010-03-15
EP1181047B1 (en) 2003-04-16
DE60002194T3 (de) 2010-02-25
DZ3160A1 (fr) 2000-12-14
WO2000074712A2 (en) 2000-12-14
SI1181047T1 (en) 2003-10-31
EG24675A (en) 2010-04-27
EP1181047B9 (en) 2010-08-25
ITRM990376A0 (it) 1999-06-09
ATE237350T1 (de) 2003-05-15
MA26792A1 (fr) 2004-12-20
DE60002194D1 (de) 2003-05-22
CN101695374A (zh) 2010-04-21
CZ20014219A3 (cs) 2002-04-17
DK1181047T3 (da) 2003-08-11
DE60002194T2 (de) 2004-01-29
IL146888A (en) 2012-02-29
WO2000074712A3 (en) 2001-05-03
ES2195902T5 (es) 2010-02-18
CN101352234A (zh) 2009-01-28
JP2003501399A (ja) 2003-01-14
EP1181047B2 (en) 2009-10-28
IS2742B (is) 2011-06-15
AU5563900A (en) 2000-12-28
SI1181047T2 (sl) 2010-02-26

Similar Documents

Publication Publication Date Title
PL375789A1 (en) Novel aromatic fluoroglycoside derivatives, pharmaceutical products containing said compounds and the use thereof
GB0214013D0 (en) Pharmaceutical product
ZA200410295B (en) Medicament dispenser.
ZA200202536B (en) Pharmaceutical tramadol salts.
MXPA01004876A (es) Producto comestible refrescante de aliento.
EE05491B1 (et) Leeliselist sfingomelinaasi sisaldav kompositsioon kasutamiseks dieteetilise valmistise, toidulisandi v?i farmatseutilise tootena
ZA200408109B (en) Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies.
ZA200204460B (en) Valnemulin formulation.
DE69930935D1 (de) Produkt, welches Psyllium-Spelze enthält
AU155150S (en) Pharmaceutical packaging
AU155083S (en) Pharmaceutical packaging
ITBO990570A0 (it) Apparecchio per il confezionamento di un prodotto alimentare , in part icolare un prodotto alimentare pastoso .
EP1556022A4 (en) Aqueous 2,6-diisopropylprophenol-containing pharmaceutical compositions
IT1311120B1 (it) Confezione per un prodotto alimentare pastoso, procedimento edispositivo per l' ottenimento di detta confezione.
ZA200002148B (en) Cereal-based product for human nutrition.
ES1042775Y (es) Envase para productos alimenticios.
ES1043721Y (es) Envase para productos vegetales.
ZA99349B (en) A pharmaceutical formulation.
ITBO990425A0 (it) Confezione per un prodotto alimentare pastoso ad apertura perfezionata .
ATA173599A (de) Pharmazeutisches produkt
ES1041733Y (es) Envase suministrador para productos alimenticios.
ES1051907Y (es) Envase para pastillas de productos farmaceuticos o parafarmaceuticos.
ES1051908Y (es) Envase para pastillas de productos farmaceuticos o parafarmaceuticos.
ES1042210Y (es) Expositor perfeccionado para productos envasados.
BR0204904B1 (pt) embalagem para acondicionar e dispensar produtos.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees